DK1098878T3 - Bispiperidiner som antitrombotiske midler - Google Patents

Bispiperidiner som antitrombotiske midler

Info

Publication number
DK1098878T3
DK1098878T3 DK99929495T DK99929495T DK1098878T3 DK 1098878 T3 DK1098878 T3 DK 1098878T3 DK 99929495 T DK99929495 T DK 99929495T DK 99929495 T DK99929495 T DK 99929495T DK 1098878 T3 DK1098878 T3 DK 1098878T3
Authority
DK
Denmark
Prior art keywords
antithrombotic agents
bispiperidines
therepeutically
fibrinogen
iib
Prior art date
Application number
DK99929495T
Other languages
Danish (da)
English (en)
Inventor
Christophe Yue
Marguerite Henry
Thierry Giboulot
Brigitte Lesur
Original Assignee
Cephalon France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon France filed Critical Cephalon France
Application granted granted Critical
Publication of DK1098878T3 publication Critical patent/DK1098878T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK99929495T 1998-07-17 1999-07-16 Bispiperidiner som antitrombotiske midler DK1098878T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9809166A FR2781223B1 (fr) 1998-07-17 1998-07-17 Bispiperidines et leurs applications therapeutiques
PCT/FR1999/001745 WO2000003986A1 (fr) 1998-07-17 1999-07-16 Bispiperidines comme agents antithrombotiques

Publications (1)

Publication Number Publication Date
DK1098878T3 true DK1098878T3 (da) 2004-02-16

Family

ID=9528732

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99929495T DK1098878T3 (da) 1998-07-17 1999-07-16 Bispiperidiner som antitrombotiske midler

Country Status (25)

Country Link
US (1) US6333338B1 (de)
EP (1) EP1098878B1 (de)
JP (1) JP2002520393A (de)
KR (1) KR100584032B1 (de)
CN (1) CN1286812C (de)
AT (1) ATE256661T1 (de)
AU (1) AU761655B2 (de)
BR (1) BR9912835A (de)
CA (1) CA2337776A1 (de)
DE (1) DE69913701T2 (de)
DK (1) DK1098878T3 (de)
EA (1) EA003674B1 (de)
ES (1) ES2212576T3 (de)
FR (1) FR2781223B1 (de)
HU (1) HUP0103623A3 (de)
IL (2) IL140581A0 (de)
NO (1) NO318963B1 (de)
NZ (1) NZ509170A (de)
PL (1) PL193804B1 (de)
PT (1) PT1098878E (de)
SK (1) SK152001A3 (de)
TR (1) TR200100159T2 (de)
UA (1) UA65631C2 (de)
WO (1) WO2000003986A1 (de)
ZA (1) ZA200100238B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2207001A (en) * 1999-12-24 2001-07-09 Smithkline Beecham Plc Novel compounds and process
CA2529486A1 (en) * 2003-06-18 2004-12-23 Nst Neurosurvival Technologies Ltd. Method for selective targeting of apoptotic cells and small molecule ligands used thereof
CA3145453A1 (en) 2019-07-01 2021-01-07 Tonix Pharma Limited Anti-cd154 antibodies and uses thereof
AU2022205313A1 (en) 2021-01-06 2023-07-20 Tonix Pharma Limited Methods of inducing immune tolerance with modified anti-cd154 antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ239876A (en) * 1990-09-27 1993-12-23 Merck & Co Inc Glycyl-b-alanine derivatives and pharmaceutical compositions thereof.

Also Published As

Publication number Publication date
PL193804B1 (pl) 2007-03-30
NO318963B1 (no) 2005-05-30
US6333338B1 (en) 2001-12-25
KR100584032B1 (ko) 2006-05-29
EA200100150A1 (ru) 2001-08-27
EP1098878A1 (de) 2001-05-16
TR200100159T2 (tr) 2001-06-21
ZA200100238B (en) 2001-11-21
UA65631C2 (en) 2004-04-15
DE69913701D1 (de) 2004-01-29
AU4629099A (en) 2000-02-07
SK152001A3 (en) 2001-11-06
PL345418A1 (en) 2001-12-17
IL140581A (en) 2006-12-31
CA2337776A1 (en) 2000-01-27
EP1098878B1 (de) 2003-12-17
PT1098878E (pt) 2004-04-30
BR9912835A (pt) 2001-10-09
HUP0103623A3 (en) 2003-01-28
NO20010252D0 (no) 2001-01-15
WO2000003986A1 (fr) 2000-01-27
CN1312799A (zh) 2001-09-12
IL140581A0 (en) 2002-02-10
ATE256661T1 (de) 2004-01-15
NZ509170A (en) 2004-01-30
EA003674B1 (ru) 2003-08-28
AU761655B2 (en) 2003-06-05
CN1286812C (zh) 2006-11-29
HUP0103623A2 (hu) 2002-02-28
FR2781223A1 (fr) 2000-01-21
DE69913701T2 (de) 2004-10-21
KR20010071925A (ko) 2001-07-31
NO20010252L (no) 2001-03-19
ES2212576T3 (es) 2004-07-16
JP2002520393A (ja) 2002-07-09
FR2781223B1 (fr) 2000-10-13

Similar Documents

Publication Publication Date Title
PT892780E (pt) Analogos de m-amidino fenilo como inibidores do factor xa
EA200000251A1 (ru) Производные резорцинола
AU7743001A (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
DE69801048D1 (de) Fungizide trifluorophenyl-triazolopyrimidine
TR199701356A2 (xx) L�kozit adhasyonu inhibit�rleri ve VLA-4-antagonistleri olarak heterosiklenler.
ATE423562T1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
ME00562B (me) Novi oblik soli pantoprazola
RS51694B (en) NEW PERINDOPRIL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THERE
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DK0700380T3 (da) N-Alkylthiopolyaminderivater som radioprotektive midler
YU11401A (sh) Lokalne farmaceutske kompozicije koje sadrže nimesulid
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
SE9901077D0 (sv) Novel use
ATE411287T1 (de) Neue metallproteinaseinhibitoren
EA200100854A1 (ru) Кальций-литические соединения
DK1098878T3 (da) Bispiperidiner som antitrombotiske midler
ATE441642T1 (de) Hydantoin derivate mit affinität für somatostatin rezeptoren
NO960190L (no) Mineralfiberblanding
SE9904660D0 (sv) Novel assays
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
BR0110800A (pt) Polipeptìdeos antiangiogênicos
DK1202754T3 (da) Anvendelse af fibrinogene multimerer i fibrinklæbere
MXPA03001440A (es) Compuestos de trioxepano novedosos.
UY24274A1 (es) Nuevos azepanes inhibidores de la proteína quinasa